Literature DB >> 25462559

Analysis of intracellular PTEN signaling and secretion.

Cindy Hodakoski1, Barry Fine2, Benjamin Hopkins1, Ramon Parsons3.   

Abstract

The tumor suppressor PTEN dephosphorylates PIP3 to inhibit PI3K signaling in cells. Altering PTEN intracellular signaling can therefore significantly affect cell behavior. Two novel mechanisms of PTEN regulation including the secretion and entry of the translational variant PTEN-L, and enzymatic inhibition by the interacting protein P-REX2, have been shown to modulate PI3K signaling, cellular proliferation and survival, and glucose metabolism. Here, we review the methods used to identify and validate the existence of both PTEN-L and the P-REX2-PTEN complex, to determine their effects on PTEN phosphatase activity, and to examine their role in cellular physiology.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  P-REX2; PTEN; PTEN-L; Secretion

Mesh:

Substances:

Year:  2014        PMID: 25462559      PMCID: PMC4861994          DOI: 10.1016/j.ymeth.2014.11.008

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  24 in total

1.  P-Rex2, a new guanine-nucleotide exchange factor for Rac.

Authors:  Sarah Donald; Kirsti Hill; Charlotte Lecureuil; Romain Barnouin; Sonja Krugmann; W John Coadwell; Simon R Andrews; Simon A Walker; Phillip T Hawkins; Len R Stephens; Heidi C E Welch
Journal:  FEBS Lett       Date:  2004-08-13       Impact factor: 4.124

2.  The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.

Authors:  J Li; L Simpson; M Takahashi; C Miliaresis; M P Myers; N Tonks; R Parsons
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

3.  Diabetes: PTEN mutations increase insulin sensitivity and obesity.

Authors:  Fiona Mitchell
Journal:  Nat Rev Endocrinol       Date:  2012-10-02       Impact factor: 43.330

4.  Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis.

Authors:  X P Zhou; D J Marsh; H Hampel; J B Mulliken; O Gimm; C Eng
Journal:  Hum Mol Genet       Date:  2000-03-22       Impact factor: 6.150

5.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

Authors:  H Sun; R Lesche; D M Li; J Liliental; H Zhang; J Gao; N Gavrilova; B Mueller; X Liu; H Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

7.  In vivo protein transduction: delivery of a biologically active protein into the mouse.

Authors:  S R Schwarze; A Ho; A Vocero-Akbani; S F Dowdy
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

8.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

9.  Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a.

Authors:  Barry Fine; Cindy Hodakoski; Susan Koujak; Tao Su; Lao H Saal; Matthew Maurer; Benjamin Hopkins; Megan Keniry; Maria Luisa Sulis; Sarah Mense; Hanina Hibshoosh; Ramon Parsons
Journal:  Science       Date:  2009-09-04       Impact factor: 47.728

10.  Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis.

Authors:  Cindy Hodakoski; Benjamin D Hopkins; Douglas Barrows; Sarah M Mense; Megan Keniry; Karen E Anderson; Philip A Kern; Phillip T Hawkins; Len R Stephens; Ramon Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

View more
  5 in total

Review 1.  Insulin-PI3K signalling: an evolutionarily insulated metabolic driver of cancer.

Authors:  Benjamin D Hopkins; Marcus D Goncalves; Lewis C Cantley
Journal:  Nat Rev Endocrinol       Date:  2020-03-03       Impact factor: 43.330

2.  PI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization.

Authors:  Marwan Mounayar; Eirini Kefaloyianni; Brian Smith; Zhabiz Solhjou; Omar H Maarouf; Jamil Azzi; Lola Chabtini; Paolo Fiorina; Morey Kraus; Robert Briddell; William Fodor; Andreas Herrlich; Reza Abdi
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

3.  Hypoxic Microenvironment-Induced Reduction in PTEN-L Secretion Promotes Non-Small Cell Lung Cancer Metastasis through PI3K/AKT Pathway.

Authors:  Xuyang Song; Jinxi He; Bingqing Shi; Yuning Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-02       Impact factor: 2.629

4.  Negative cross talk between LIMK2 and PTEN promotes castration resistant prostate cancer pathogenesis in cells and in vivo.

Authors:  Kumar Nikhil; Mohini Kamra; Asif Raza; Kavita Shah
Journal:  Cancer Lett       Date:  2020-09-12       Impact factor: 8.679

5.  Autism-associated PTEN missense mutation leads to enhanced nuclear localization and neurite outgrowth in an induced pluripotent stem cell line.

Authors:  Chi Wai Wong; Yubing Wang; Tian Liu; Lisha Li; Stanley Kwok Kuen Cheung; Penelope Mei-Yu Or; Alfred Sze-Lok Cheng; Kwong Wai Choy; Johannes Peter Henri Burbach; Bo Feng; Raymond Chuen Chung Chang; Andrew M Chan
Journal:  FEBS J       Date:  2020-03-26       Impact factor: 5.542

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.